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ABSTRACT 
MASS SPECTROMETRY BASED FREE RADICAL INDUCED 
FRAGMENTATION STUDY OF CHEMICALLY MODIFIED CYSTEINE 
CONTAINING PEPTIDES 
by 
Veronika Vitalyevna Dubniakova 
May 2012 
Modification of cysteine containing peptides by the thiol group of cysteine with radical 
precursors allows a simple and localized generation of radical species in the collision cell 
of mass spectrometer. The proof of principle and the analysis of the radical derived 
fragments of a set of different model peptides are described further in the manuscript as 
well as the importance and potential applications of the method. 
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CHAPTER I 
INTRODUCTION 
1 
The global idea of the project is to advance the knowledge of gas-phase digestion 
ofpeptides in mass spectrometry. The aim is to study radical derived fragmentation 
patterns of peptides. Radical species will be introduced by means of chemical 
modification of cysteine; the fragmentation will be stimulated and analyzed by means of 
mass spectrometry. The topics covered in the background gradually introduce the main 
concepts from different areas required for the understanding of the project origin and 
importance. First, the concept of the peptide structure is introduced, followed by the 
importance and applications of proteomics. Second, the development of sequencing 
techniques is briefly stated, followed by the application of mass spectrometry as a 
sequencing technique. Then an introduction of the interpretation of the fragmentation 
patterns of peptides and mechanisms of the fragmentations are generally introduced. 
Lastly, the background section is finished by the overview of the work conducted in the 
radical fragmentation of the pep tides achieved through chemical modification. 
Background 
Protein Structure 
All living organisms are composed of four main classes of components apart from 
water. These components are nucleic acids, proteins, fats, and carbohydrates. In terms of 
function, proteins are the most diverse class.' Proteins are polymeric structures composed 
of monomer units of amino acids. They have several structural levels. The formation of 
each level depends on the previous level. 
2 
Figure 1. General amino acid structure. 
There are 20 naturally occurring amino acids. Some of these occur in proteins 
more frequently than others. All amino acids differ by the R group (Figure 1 ), and can be 
categorized by side chain (-R) chemical properties such as: aliphatic, aromatic, neutral, 
basic, acidic, sulfur-containing, and imino acid. The different side chains are responsible 
for the diversity seen in protein structure. For example, a three amino acid peptide could 
be made of203 combinations of the amino acid sequences (8000 different variants). 
In a protein, amino acids are connected by a peptide bond (Scheme 1 ). The 
peptide bond is formed by dehydration. The amino acids joined by a peptide bond form 
the primary structure of a peptide. The chemical properties of the amino acids' side 
chains in the primary structure play an important role in further protein assembly. 
Scheme 1. Formation of the peptide bond. 
All amino acids occur with different frequency in proteins (Table 1)1 
Table 1 
Occurrence of amino acids in proteins (%). 1 
Amino Acid % Amino acid % Amino acid % Amino acid % 
Table 1 (continued). 
Amino Acid % Amino acid % Amino acid % Amino acid % 
Glycine 7.2 Isoleucine 5.3 Serine 6.8 Lysine 5.9 
Alanine 7.8 Methionine 2.3 Threonine 5.9 Histidine 2.3 
Proline 5.2 Phenylalanine 3.9 Cysteine 1.9 Arginine 5.1 
Valine 6.6 Tyrosine 3.2 Aspargine 4.3 Aspartate 5.3 
Leucine 9.1 Tryptophan 1.4 Glutamine 4.2 Glutamate 6.3 
Once the sequence is assembled, a secondary structure is formed by hydrogen bonding. 
This hydrogen bonding is formed between amino acids in different locations. There are 
two types of secondary structures: a helix and p sheet. The last three dimensional 
arrangement of peptides is the tertiary structure. This structure is formed due to multiple 
non-covalent interactions between amino acids. In some cases a quaternary structure can 
be observed. The quaternary structure is the coordination of several separate peptide 
subunits in a protein complexes formed as a result of multiple covalent interactions. 1 
There are multiple books and articles that describe protein structure in great detail. 1' 2' 3 
3 
There are certain amino acids known as proteinogenic amino acids which are 
responsible for protein formation. There are 22 standard proteinogenic amino acids, 21 of 
them are found in eukaryotes, and only 20 of them are encoded by the genetic code. The 
other two amino acids (selenocysteine and pyrrolysine) are incorporated into proteins by 
a specific mechanism. 
0 
OH 
selenocysteine YrNH 
pyrrolysine 
Figure 2. Uncommon amino acids. 
I o 
-w II _ /~0 
betaine 
0 
H2N~OH 
NH2 
ornithine 
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There are also non-proteinogenic amino acids. These amino acids are either not 
found in proteins (betaine, ornithine) or not produced directly by cellular machinery (post 
translational modification). Non-proteinogenic amino acids possess important regulatory 
functions (betaine) or represent intermediates in metabolic pathways (omithine).4 Amino 
acids in the sequence of a protein can get modified to produces uncommon amino acids. 
Post translational modification broadens the functions of proteins by attaching new 
functional groups. 5 Identification of sequences of pep tides with post translational 
modification represents a great research interest and challenge. Post-translational 
modification usually compromises chemical modification of an existing amino acid and 
occurs with the help of a specific enzyme.5 For example, hydroxylation is a chemical 
reaction that introduces a hydroxyl group into an amino acid, and is catalyzed by 
enzymes hydrozylases. Proline may be hydroxylated on its ~-C atom and lysine may also 
be hydroxylated on its &-C atom forming two amino acids that are present in collagen: 
hydroxylysine and hydroxyproline (Figure 3). 
VOH OH 0 H2N~OH NH2 
Hydroxylysine 
NH 0 
HN)lN~OH 0 0 
I H NH2 H~J--oYoH NH2 
HO Hydroxyproline Methylarginine PhosphoSerine 
Figure 3. Examples of posttranslational modifications of amino acids. 
Methylation of amino acids in peptide is another example of post translational 
modification. Some muscle proteins contain methylated residues.6 Methylation takes 
place with the basic amino acids: arginine, lysine, and histidine. Phosphorylation is one 
of the most important regulatory mechanisms. Enzymes that catalyze this process are 
called kinases and phosphatases. This process serves as a switch between the active and 
inactive conformation of an enzyme. As an example, regulation of fructose 2,6-
bisphosphate levels are controlled by the phosphorylation of the bifunctional protein. In 
the case of phosphorylation, when the concentration of fructose 2,6-bisphosphate is low, 
glycolysis is inhibited. Following this the break down of phosphates increases the 
concentration of fructose 2,6 bisphosphate stimulating glycolysis (Figure 4). 1 
Phosphorylation can occur on serine, threonine, tyrosine, and histidine residues. 
5 
t F26BP 
stimulates glycolysis, 
inhbits gluconeogenesis 
p.~ 
insulin · - ~- --; 
H20 
• F26BP 
Inhibits glycolysis, 
stimulates gluconeogenesis 
IPFK-2 I 
I active L-oH 
\FBPase-2\ ~ . ATP 
\inactive \ .lonon~A- _ _ ____ glucagon 
cAMP-depend ADP phos~ho- protein kinase ~ 
protem 
phosphatase 
Figure 4. Phosphorylation of a bifunctional protein. 1 
Phosphorylation is one of the ways of regulating the activity of the peptides and 
proteins, and it is a very important control mechanism, because peptides have many 
functions . In living organisms, these functions can vary from structural to enzymatic to 
signal functions. The function of a newly isolated peptide is a great research interest in 
the field of proteomics. Proteomics is the study of proteins, and is mostly devoted to the 
proteins' function, structure, and interaction. 
Importance of Proteomics 
Proteomics is analogous to genomics, the study of genes. Much like how a 
genome is a set of genes of a particular organism, a proteome is the entire set of proteins 
expressed by the genome of a cell or tissue over a period of life. Since the genome is the 
entire set of heredity information of an organism, one could expect all the proteins 
synthesized by the organism to be coded in the genome. However, the research of the 
Human Genome Project showed that the human genome contains 40-50 times less genes 
6 
than there are proteins in the human proteome.7 Such large diversity in the protein 
structure is explained by post translational modifications and alternative splicing. 7 
7 
Proteins' wide variety of functions plays a main role in the life cycle of living 
organisms. The expression of one kind of protein can be constant throughout a whole 
organism or it may vary depending on the tissue, the life period, or the ecological 
environment. Varied concentrations of proteins at different conditions can serve as 
biomarkers of abnormal health conditions and abnormal environmental conditions. 8 
These properties have allowed proteomics to be used in medicine, food industries, and in 
drug discovery. In medicine, urine and blood samples are being studied for the presence 
of disease protein markers.9 In food industries, proteomic approaches have found wide 
application in plant-based food areas. 10 The understanding of the biochemical processes 
involved in fruit ripening allows for the identification of protein markers showing 
specific horticultural quality aspects. This also allows companies to detect optimum 
harvest maturity. The study of protein change in plant-based foods and their different 
responses in post harvest storage techniques has lead to longer shelf lives and the 
optimized processing techniques. 11 Proteomics is also used in "allergenomics", the study 
of protein-based allergens. These are just several examples of the application of 
proteomics; one can find a more detailed and complete review of the applications of 
proteomics in recently published review papers. 12• 13 
Development of Sequencing Tools 
The large amount of applications of proteomics has rekindled the interest in many 
scientific branches. Some ofthe current branches ofproteomics are: protein separation, 
protein identification, protein quantification, protein sequence analysis, structural 
8 
proteomics, interaction proteomics, protein modification, cellular proteomics, and 
experimental bioinformatics. The development of different areas of proteomics has led to 
the development and modification of the tools used by scientists. As a result, protein 
sequencing techniques have evolved. One of the first protein sequencing methods was 
based on the Edman degradation (Scheme 2). 1 
Polypeptide +o-N=C=S sc.Tl H2 o R3 H o ONH-~ rNJY~YlNAyN0oH 
Phenylisothio- H 0 R2 H 0 R4 cyanate 
repeat 
the cycle Q Q CF3COOH + 0 R3 H 0 H+ + H3N0~AyN00H s~~o HNf=N 
R2 0 R4 S~R1 HN One amino acid R1 
shortened peptide 0 Phenylthiohydantoin 
adduct of terminal 
amino acid 
Scheme 2. Edman Dergradation. 
This method was widely applied, and is still used today in automated sequencers. 
The main draw back of this technique is that no more than 50-60 residues can be 
sequenced at a time. However, to avoid this problem, large proteins are subjected to 
enzymatic digestion and gel separation before sequencing. 14 
A relatively new technique for protein sequencing is mass spectrometry. Mass 
spectrometry is an analytical technique which measures the mass to charge ratio of a 
charged analyte. Mass spectrometry characterizes the mass or the elemental composition 
of an analyte. There are several books published with a full description of mass 
spectrometry. 15' 16 
9 
Initially, mass spectrometry application in proteomics research was used to 
characterize already known peptides and proteins. Several databases of the mass 
spectrum of known peptides and proteins were created. These databases were used to 
quickly compare a newly separated peptide spectrum. This quick comparison allowed 
chemists to determine if a protein had already been described. It also allowed them to see 
which proteins a newly discovered protein was related to structurally. Since the 
development of different ionization techniques and analyzers, mass spectrometry is 
capable of processing the whole protein sequence. Mass spectrometry based sequencing 
techniques are the least time consuming and have a high -throughput. 
Mass Spectrometry as a Sequencing Tool 
The use of Mass-spectrometry as a sequencing tool became popular recently due 
to the convenience in sample preparation and its speed of analysis. Mass spectrometry not 
only allows de novo sequencing, 17 but also gives an opportunity to elucidate the locations 
of covalent modifications in peptides and proteins. 18 
As for peptide analysis, tandem mass spectrometers represent the most value, 
since they allow several rounds of analysis on a selected mass. Ion trap allows retention 
of the mass of interest with further collision and analysis of the obtained daughter ions. 
More detailed description of a mass spectrometer can be found in a manual. 15 
The use of mass spectrometry as a sequencing technique helps to make 
complicated and time-consuming analysis faster, which stimulates fast advancement of 
scientific knowledge. A key part in peptide sequencing analysis is the ease of data 
interpretation. Currently, research is devoted to fragmentation pattern predictions, since 
10 
chemical processes of proteins in mass spectrometers are not fully understood. Therefore, 
one can not precisely predict the fragmentation pattern of an individual protein sequence. 
However, there are several models that can ease the fragmentation interpretation process, 
and a wide range of databases of protein/peptide fingerprints . The interpretation of 
spectra becomes more complicated as the molar weight of peptides increases, since more 
of fragments are being produced. 
It has been established, that fragmentation patterns depend on several aspects of 
the experiment: 19 
(1) use ofthe ionization technique 
(2) mass of the analyzed peptide 
(3) the presence of basic amino acids 
( 4) the presence of chemical modifications in the sequence. 
The choice of the ionization technique- low-energy (soft) or high-energy (hard) -
defines the possible reactive species that can be formed in the mass spectrometer and 
further undergo fragmentation to produce the spectra. The most wide spread ionization 
technique is ESI ( electrospray ionization), not to be confused with EI (electron 
ionization) technique. The mechanism of ionization by the first technique involves 
dispersing a solution of an analyte by electrospray into a fine aerosol (the process 
involves the solvent evaporation and ion formation), and the formed ions are protonated 
or cationized adducts of the analyte. In the second case, the ions of the analyte are 
produced through the interaction of high energy electrons with gas phase atoms of the 
compound, which stimulates the formation of radical species. 
11 
Over time, ESI became the most wide spread ionization technique?0 As for 
dissociation techniques used in tandem mass spectrometry, the spectra obtained by ECD 
(electron capture dissociation) and CID (collision induced dissociation) will differ, 
because ECD stimulates the formation of radical species on the peptide backbone 
resulting in peptide side chain loss or radical induced fragmentation. On the other hand, 
CID fragments peptides by colliding them with an inert gas. In most cases, this technique 
does not produce any radical species and yields mostly backbone fragmentation. 
ESI CID is mostly used for the analysis of small peptides <2000 Da. Due to the 
compatibility of ESI with the Ion Trap, the further generation of the daughters of a 
selected ion can be analyzed. In other words, it is the ionization technique of choice for 
tandem mass spectrometry. There is a range of other ionization techniques used in 
proteomics research. However, ESI is the most wide spread and accessible technique, the 
description of other techniques can be found elsewhere. 15 When talking about ESI in 
terms of peptide fragmentation pattern study, high energy ESI and low energy ESI (soft 
ionization) produce different fragments. The main difference between the two sub-types 
of ionization is that the soft ionization technique does not show side chain cleavages such 
as those that occur from previous studies. The soft ESI only leads to the immonium 
ions.20 
Today de novo sequencing is done mostly with the help of mass spectrometry. 
Since the spectrum of large peptides gets very complicated to interpret, it makes sense to 
subject proteins to enzymatic digestion followed by the mass spectrometry analysis 
(Figure 3). 14 
enzymatic ~ 
digestion 1 ¢J 
12 
LC-MS 
~-
new protein L 8 sample 
easy to interpret 
spectra 
Data 
analysis Sequence 
generation 
enzymatic • 
digestion 2 
LC-MS ~-
easy to interpret 
spectra 
Figure 5. The peptide sequencing with the help of MS. 
At the moment, one of the aims of proteomics research is to get mass spectrometry to the 
point when no digestion would be required.19 
~ MS MS2 II~ I I I on the key I J new protein fragments 
sample spectra with easy to interpret 
they key fragments spectra 
Figure 6. Top-down peptide sequencing. 
To get to that aim, one must work on simplification of the spectra interpretation. 
Previously, research has been done to understand the fragmentation behavior ofpeptides, 
resulting in several theoretical hypotheses. 
Mobile Proton Concept 
Mobile proton concept explains the peptide fragmentation tendencies in a mass 
spectrometer. The concept was suggested by the group of Wysocki,21 after observations 
of the fragmentation efficiency curves of a set of peptides. It was noticed that the peptides 
of the same quantity of amino acids require different amounts of energy to initiate 
13 
fragmentation. They observed the energy input requirement increases with the 
appearance of a basic amino acid. Further studies examined the influence of the location 
of a basic amino acid on the energy required for fragmentation initiation. 22 They found 
that the energy required for the peptide dissociation correlates to the basicity of the amino 
acids in the sequence (calculated basicity ofthe 20 amino acids in the gas-phase).23 
Gly < Cys < Ser, Asp< Ala, Val< Leu, lie< Phe, Tyr, Asn 
< Thr, Met, Gin, His <Pro, Trp < Glu < Lys < Arg 
Proton Affinity/ Gas- Phase Basicity 
Figure 7. Relative basicity ofthe 20 amino acids in the gas phase. 
Thus a mobile proton model emerged. The Mobile Proton hypothesis suggests that the 
charge (proton) is mostly picked up by the most basic site in the peptide. The more basic 
the location is, the higher the affinity to the proton this location is compared to the other 
locations on the peptide. In the presence of a basic amino acid, it is the side chain of the 
basic amino acid that predominantly becomes protonated. Once energy is applied to 
protonated peptides, the energy has to be higher than the proton affinity of the group 
withholding the charge. Only in this condition, will the fragmentation occur by means of 
proton migration to a less basic location on the peptide which is usually followed by 
backbone breakdown. Thus, the fragmentation mechanism is called charge directed. The 
peptides with no basic amino acids in a sequence require less energy input to initiate the 
fragmentation. To logically predict potential sites of backbone fragmentation one needs 
to consult the gas-phase basicities of the amino acids present in the peptide (Figure 5). 
Proline needs to be mentioned separately; due to its rigid structure, and steric hindrance, 
14 
it requires more energy input to start the fragmentation. There is another circumstance 
that needs to be taken into account. When the proton is "solvated" by several heteroatoms 
on the backbone of peptide, it has been shown that it will predominantly reside on the 
carbonyl oxygen, since it is more basic than amide nitrogen?2 
Another behavioral pattern was proven to take place: internal nucleophilic attack. 
The theoretical and experimental research was conducted by O'Hair.24 The location of 
the cysteine residue plays an important role. When cysteine is located by theN-terminus, 
loss ofNH3 is observed. If the cysteine is located in the middle of the peptide, loss of 
H20 takes place with subsequent internal cyclization. 
Scheme 3. Loss ofNH3 when cysteine is located by theN-terminus. 
Scheme 4. Loss ofNH3 when cysteine is located in the middle of a peptide. 
Schlosser et al. examined the importance of intramolecular nucleophile-electrophile 
interactions of the side chain and the backbone of peptides in low-energy collision 
induced dissociation?5 The study demonstrated the tendency of peptides to form 5-
membered ring structures in gas phase when the interactions take place. Even though the 
3 and 6 membered cycles were also described earlier, this study demonstrates that the 5-
membered ring formation is more efficient in terms of the energy structural principle. 
15 
There is also a review by O'Hair of the nucleophilic -electrophilic reactions within the 
peptides, which states that since it is hard to prove the gas-phase mechanism of peptide 
fragmentation, one has to be very careful when making any conclusions.24 
Nomenclature of Peptide Fragments 
Standard nomenclature of peptide derived ions obtained in tandem mass 
spectrometry was introduced by Roepstorff and Biemann?6• 27 This nomenclature covers 
the fragments formed from the breakdown of the backbone of the peptide. Once the bond 
is broken only one of the formed fragments gets to keep the positive charge, therefore 
only one of the fragments is observed, since only charged species are seen in the mass 
spectrum. Depending on which bond is broken and which side gets to keep the charge the 
fragments are named a, b, c- if the charge stays on N-terminus and x, y, z, ifthe charge is 
fixed on the C-terminus. The subscript number defines how many amino acids are in the 
residue (Figure 8). 
Figure 8. Nomenclature ofthe peptide fragments in MS. 
Charge Remote Fragmentation 
Aside of charge directed fragmentation model there is also charge remote 
fragmentation. Charge remote fragmentation model is applied if the fragmentation takes 
place away from the charge bearing location on the peptide. The charge remote 
fragmentation takes place in so called distonic ions, the ions that contain radical cations. 
Since the radicals are very reactive species they start fragmenting at the lower energies 
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than in the case of charge directed fragmentation. There are several ways of introducing 
radical species on a protonated peptide. The fragmentation pattern of the charge remote 
model differs from the charge directed, since different kind of chemical interactions I 
reactions take place. To describe the charge remote fragmentation pattern of the peptides, 
the Even Electron Rule needs to be introduced. 
Even Electron Rule 
The Even Electron Rule is a rule based on the comparative analysis of different 
types of mass spectra of peptides. The decomposition pathways were statistically 
analyzed by Miriam Karni and Asher Mandelblaum?8 Based on the analyzed data they 
came to a conclusion that the fragmentation depends on the nature of the ionized species. 
Over the years, the fragments of different ionized species were observed and a 
generalization of patterns was written down as a rule. The"Even electron rule" states that 
the even electron cations can only eliminate neutral species with a formation of another 
even-electron cation (Scheme 5). 
Scheme 5. Fragmnetation of the even electron species. 
The odd-electron cations can decompose in two possible ways: formation of radical and 
even electron cation or formation of a new odd-electron and a neutral species (Scheme 6). 
• + + • [RXj- [Rj [xj 
•+ • + [RXj- [Rj [xj 
Scheme 6. Fragmentation of the odd electron species. 
The odd electron species are basically free radical species. 
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Free Radicals 
Free radicals are the species formed by holomytic dissociation of a bond. Once 
the free radical species is generated, the species is extremely reactive; it can undergo 
several reactions including fragmentation reactions. This property of the radial species is 
widely used in the peptide mass spectrometry to stimulate fragmentation at or near the 
radical derived spot. The reactions of generating free radical described below have been 
used in generating radical species in peptides. The most common way of introducing a 
radical is by specific modification of the side chain amino acid and further activation of a 
radical bearing species. For example, nitrogen monoxide is known as a radical generating 
particle that takes part in many different biological processes of radical character.29 
Nitrogen monoxide has been introduced on the cysteine30, 31 and serine29 followed by 
activation (Schemes 7 and 8) to generate the radical species. 
I GSNO CID ~-SH - R- S- NO --. 
Scheme 7. Radical species formation from cysteine. 
hv 
-
Scheme 8. Radical species formation from serine. 
R-S·I 
The principle of generating the radical species by exposing carbon-halogen bond to 
266nm light (Scheme 9) has also been applied to peptides.32 
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266 nm ~NQ  ~;; 
F 
Scheme 9. Radical formation by hv. 
Another principle used in chemically derived radical generation is the dissociation of the 
peroxy ester bond (Scheme 1 0). 
-
Scheme 10. Radical formation from a peroxyester. 
All the radicals described above are hydrogen deficient radicals, and in a mass spectrum 
they would also carry a charge and are hydrogen deficient radical cations. 
When discussing free radical species applied to peptides in mass spectrometry, aside 
from the homolitic dissociation of a bond in a radical possessing molecule, radical 
species can be formed using two dissociation techniques. 
ECD (electron capture dissociation) - introduces low energy electrons to the 
analyte in gas phase and ETD (electron transfer dissociation)- introduces low energy 
electrons through an anion radical donor.33 In dissociation techniques, hydrogen rich 
cations are formed. It was noted that the fragmentation pattern of hydrogen rich and 
hydrogen deficient radicals are different.34 
Once the radical species is generated it could potentially migrate. There have been 
several studies on peptides to identify if newly formed radicals can potentially migrate.35 
Research has indicated that migration capability depends on the location of the radical. 
One paper describes a theoretical study. The initial radical changes by occurrence of the 
intramolecular hydrogen atom transfer (HAT).36 
19 
There are three types of HAT 
(1) backbone to backbone 
(2) side chain to backbone 
(3) side chain to side chain 
The loss of side chains is observed and speculated to be proof of radical migration.37 In 
another study, the backbone radical is shown to be localized and the migration is absent. 
The results were supported by the stability of the location of the radical having the 
captodative effect.38 
The reaction responsible for the radical derived hydrogen atom transfer is thought 
to be the hydrogen abstraction by the hydrogen species (Scheme 11 ). 
R R 
r-1 I 
,...._;-.,\ c ·c x· H" I 'R-x-H+ I'R 
R R 
Scheme 11. Hydrogen abstraction. 
The reaction explaining following hydrogen abstraction fragmentation can be described 
asP-elimination (Scheme 12). 
e-c 
. H, y+ v--
t 
0 
charge retention 
charge migration 
Scheme 12. P-elimination. 
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Charge remote Fragmentation 
Hydrogen rich radical cations. Electron capture dissociation (ECD) and electron 
transfer dissociation (ETD) are the two dissociation techniques of choice, when the 
radical derived fragmentation pattern is the piece of information of interest. The main 
difference of the techniques is that in ECD the selected parent ion is subjected to very 
low-energy electrons and then fragmentation is observed. While in ETD the parent ion is 
collided with an anion species, and acquires an electron from this species. From the point 
of possible control, this way of generating the radical species is not the most efficient, as 
the biggest problem is that it is hard to identify where precisely the electron ends up after 
being generated. However, several models based on the fragmentation pattern were 
proposed:34 
Cornell mechanism suggests that the radical is being captured at the positive site 
of the peptide to form a hypervalent radical center, followed by energy release leading to 
a ground state. Once the ground state is reached, the formed hypervalent species could 
release or eject a proton forming c/z fragments or in case of the presence of thionyl 
group: reduced SHand S*.39 
Another mechanism, Utah-Washington mechanism, suggests radicals don't have 
to be captured at the protonated site, but directly at the fragmentation site (either S-S 
bond or -HN-a.C -).Both of the theories were examined by quantum calculations and 
modulations.40 In general, in ECD and ETD in addition to b/y fragmentation one can 
observe z/c fragments, which provide extra information about the peptide sequence. 
When talking about side chain fragmentation, it has been shown that hydrogen rich 
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radicals are undergoing transformation into the hydrogen poor radicals. There are several 
mechanisms, suggested by Julian, detailing how this occurs.41 
Hydrogen Deficient Radical Cations. The hydrogen deficient radical cations of peptides 
are usually generated by chemical modification with a radical precursor substrate 
(molecules that can be converted into a radical under some specific conditions.). 
+ X -
Scheme 13. Chemical modification of a peptide. 
The most common ways of generating radical derivatives from the chemical modification 
are: collision induced dissociation or exposure to several wavelengths of light. 
CID 
or 
hv 
R1 H 0 R3 H 0 H3N~N0~~N00H 
0 .R2 0 R4 
X 
Scheme 14. Radical species generation from a chemical modification. 
The chemical modification method of generating radicals is more precise. This is why it 
represents a bigger value to the research in understanding the fragmentation pattern. The 
ways of introducing the chemical modification can be classified by activation of the 
radical bearing fragment: photoactivation, collusion activation. 
Photoactivation. 
It has been shown that the peptides can be degraded when exposed to UV light.42 
The degradation takes place through the intermediate radical containing species. The 
generation of radical species in the protein sequence with the help ofUV light was 
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studied on different models. For example, the peptide radical species were generated by 
exposure of a range of peptides to 15 7 nm light. All the studied pep tides contained 
arginine in the c-terminal position and showed to produce x, v and w ion fragments.43 
The radical species in the peptides can be also created by introduction of a chemical 
modification, which generates radical species when exposed to several wavelengths of 
light. As an example, the tyrosine side chain was selectively iodinated in a range of 
peptides and subjected to radiation at 266nm, generating highly localized radical 
. 44 
spectes. 
Basically, the fragmentation was found to be localized around the Tyrosine 
residues (or histidine), producing predominantly a-type fragments on the c-terminal of the 
modified reside. The interesting fact is that x fragments are not occurring, mostly "a" 
fragments are observed. The other fragments were distributed equally throughout the 
spectra.44 
Another researcher used a crown ether complex with iodine modification on the 
side to generate radicals by the same mechanism.45 In this research the mechanism was 
discussed and suggested: 
( 1) The generated radical abstract a.-hydrogen from the side chain 
(2) P-elimination 
In the end primary a-type fragments are generated. 
There is another way of generating the radical species using Cu complexes. One 
ofthe ways of generating the radical species in the peptides was first described by Chu et 
al.46 They were using Cu as a metal and this method is limited in application, it works if 
the oligopeptide contains tyrosyl and a basic residue (arginyl, lysineyl, histidyl). The 
presence of a basic amino acid is crucial, otherwise only M+ was generated. 
Although later Chu et a! managed to obtain the radical species of peptides containing 
aliphatic amino acids with help of 12 crown 4.47 
Later several different ligands were examined, and it was concluded that: 
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(I) tridentate ligands give better result in generation of the peptide radicals, since 
they chelate the metal better promoting the dissociation of the peptide and radical . 
(2) ligand should have no acidic protons since after the coordination of the L to Cu, 
the acidity of the proton increases~ higher possibility ofthe proton migration. 
M+ produced instead of radical species. 
The main purpose was to find the best ligand for the most effective radical generation. 
The mechanism for generating the radical is as follows: 
(1) The peptide is coordinated in a complex with a transitional metal and a ligand 
(2) CID on the complex results in homolytic dissociation, causing the reduction of 
metal and oxidation of peptide to the cationic peptide radical. 
(3) The peptide is further separated to analyze the chemistry of the radical. 
In the further studies, different ligands and cations were examined. And it was shown that 
the competing pathways of the fragmentation are the same, and varying the metal can 
help tune up the complex for better radical generation.48 
Chemical Modification 
The chemical modification of peptides also introduces the radical precursor. In the 
collision cell, this precursor is transformed into radical species.49 Previous research in 
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chemical modified peptides with radical precursors was conducted using 
peroxycarbamates.50•51•52 Peroxycarbomate modification was introduced by the terminal 
amino group and by the amino group on Lysine. 
0 
A. 
H 0 
l(N 0 / 
R""ol(o' ok 0 pH= 7.5 - 8.5 
+ 0 -
NH2 
B. 0 R""ol(o'ok pH= 5.5 
/yNH2 
+ 
-
0 R 
Scheme 15. A. Modification oflysine with peroxycarbonate. B. Modification ofN-
terminus with peroxycarbonate. 
Several different peroxycarbonates were used for the modification. The peroxycarbonates 
(Figure 9) differ by their reactivity. Compound #1 modifies both sides but lysine is more. 
Compound #2 is better for N-terminus, compound #3 was found to be the most reactive 
(the reaction times are shorter when compound #3 is used). 
0 
o,N-Q-o)lo,o-f 
1. 
Figure 9. Used peroxycarbonates. 
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The research showed that modification takes place on both amino group sites. Although 
in basic conditions the lysine site is modified predominantly and in slightly acidic 
conditions better selectivity for theN-terminus was achieved. 5° Varying available 
peroxycabonates also showed that the modification efficiency depends on which 
peroxycarbonate is chosen. (The choice of the peroxycabonate for the modification also 
allows tuning up the efficiency of the reaction). 
The modification was used for 2 different studies with the same idea. The gas 
phase digestion of peptides, would introduce some clues for the simplification of spectra 
interpretation. Thus the chemistry of fragmentation is shown to start at the weak peroxy 
bond: 0-0 decomposition followed by decarboxylation. The radicals obtained are called 
aminyl radicals (Scheme 16). 
The intensity of the aminyl radical reaches maximum at about 18 e V, meanwhile 
the energy offset required to reach the peptide backbone fragmentation is usually >30eV. 
H 0 H 0 
YN 0 / YN 0 / 
1) 0 CID 0 
Lt - u+ 
HNl(o'oJ< ~H 
0 
2) CID 0 
OH k - Jly. NH 
JYN+J(o' o R Lt 
RLiO 
Scheme 16. Formation ofthe aminyl radicals (1) from the lysine modified peptide (2) 
from the N-terminus modified peptide. 
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The radical species stimulates the peptide fragmentation to occur, and in the case ofN-
terminus modified peptide, the terminal amino acid loses the side chain. 
CID 
Scheme 17. Fragmentation of the N -terminus derived radical: loss of side chain. 
In the case of the lysine modification, the radical migration by hydrogen abstraction is 
observed to be followed by ~-fragmentation. The following remote hydrogen abstractions 
were also observed: 1, 5-migration through a 6-membered transition state followed by ~-
fragmentation (product 2 and 5 Scheme 18), sometimes 1, 5-migration is followed by 1, 
2-migration and only then ~-fragmentation takes place (product 3 Scheme 18) or 1, 4-
migration is also observed through 5-member ring transition state (product 4 Scheme 18). 
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Scheme 18. Lysine derived aminyl radical fragmentation. 
The fragmentation of the peptide depends on the location ofthe radical species: thus 
when the radical species is generated on theN-terminus: the loss ofthe side chain is 
observed. When the radical is located on the lysine nitrogen, the fragmentation of lysine 
and the breakdown of lysine's backbone are observed. This creates a manipulative tool, 
giving extra information from the fragmentation of the radical species. The fragmentation 
of the protonated species was also studied, it was found that the fragmentation patterns of 
the protonated species differ from the fragmentation pattern of the cation adducts. In the 
CID on cationic adducts of modified peptides, one can usually observe more of radical 
derived fragmentation to take place, this behavior can be explained by the absence of 
possibility of a proton migration, unlike in protonated adducts. 
28 
Another approach to radical generation is theN- nitrosation of tryptophan 
containing peptides.53 The obtained adduct yields radical species upon CID. The 
fragmentation study shows backbone fragmentation (mostly a-type fragments) near the 
tryptophan or the side chain loss. The most common observed side chain loss is from 
tryptophan itself. The fragmentation was shown to depend on the presence of basic amino 
acids, since the ability to isolate the proton from the radical source stimulates radical-
induced fragmentation. On the other hand, the lack of basic amino acids in the peptides 
shows the standard b/y fragmentation with some side-chain loss. 
H 0 
I H 0 yN y I H 0 yN y yN0 / >-
-:?" CID 1. I ~ -:?" ~ ') 
- cQ ~ I N ~ \ I t:J_) NO 
Scheme 19. Radical species formation. 
The main idea behind S-nitrosilation is to introduce the NO group upon the 
incubation with S-Nitrosoglutathione as a NO-donor group.30 The amino acids modified: 
cysteine and tryptophan. Further, once subjected to CID they generate radical species in 
the place of modification. Observed and proposed mechanism: 
( 1) The generated radical abstracts the hydrogen from P-carbon. 
(2) p fragmentation takes place on either side of a-C to generate 
As a result either alx+ 1 or c-1/z ions are generated. The protonated nitrate esters 
experiment was set up on serine, and it was converted into homoserine nitrate ester. The 
purpose of this study was to define the reactivity of the generated radicals. 
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Modification ofCysteine. 
The possibility of nucleophilic substitution at the sulfur and a low occurrence in 
the natural peptides makes cysteine an important spot for introducing a modification. 
This property is widely used in nature: cysteine is shown to be involved in a range of 
enzymatic reactions;54 it is also shown to play a role in protein damage. 55 
Modification of cysteine takes place in mild conditions and occurs very selectively, this 
is why cysteine is often chosen as a modification site for radical generation in mass 
spectrometry. 
In addition to the reactions for tautomeric interconversion, Hopkinson at al. 
examined structures and relative energies of different kids of tautomers of the cysteine 
radical cation. 56 It was found that the most stable tautomer has a captodative structure, 
having unpaired electron on the a-carbon and charge on the protonated carboxyl group. 
Another stable tautomer is a distonic ion with the radical on the sulfur and charge at the 
protonated amino group. Unfortunately the authors did not manage to generate the 
cysteine radicals by EI, since the loss of COOH* was the lowest energy process. 
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Figure 10. Different forms of cysteine. 
Another study of the gas-phase fragmentation reactions of cysteine containing tri 
and di peptides was conducted. 30 The radical precursors were generated by reacting 
cysteine residue with the NO donor. The radical generation used CID, and the 
fragmentation observed produced mostly stimulated a C-C and a C-N bond breakdowns, 
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yielding a/x and c/z types of ions. Additionally, the side chain loss of cysteine was 
observed. It was also noticed that peptides with radicals generated regio-specifically at 
the cysteine give x-type sequence ions via radical type cleavage at sites which are several 
residues away from the initial S-centered radical. 
There is new research on the different locations of the radicals, generated by two 
different techniques, described before: nitrosylation by the cysteine residue and the Cu 
complex by the tyrosine residue.35 
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Hypothesis: 
Hypothesis 1: Cysteine can be selectively modified with 5-bromo-t-butyl ester of 
peroxypentanoic acid. 
Hypothesis 2: The radical derived peptide fragments will occur, once the modified 
peptide is exposed to CID. 
In my research I am interested in introducing the chemical modification by 
cysteine residue due to the fact that cysteine residues are occurring less often than lysine. 1 
The modification can occur predominantly on one or the other nitrogen, but to some 
degree it occurs at both locations. Having cysteine as a modification spot, I would be able 
to limit the modification spots and avoid the need in adjusting pH values. In case the 
modification takes place selectively by cysteine mass shift should also be observed before 
CID is performed. The magnitude of the mass shift would allow predicting the amount of 
cysteines present in a newly isolated peptide, which would also simplify the sequencing 
process. I would like to analyze the radical derived fragments distribution on several 
model peptides to find out how different locations of cysteine affect the modification and 
fragmentation pattern. The radical derived fragments could serve as a supplementary 
source of structural information when sequencing newly isolated peptides. As a model 
peptide for proof of concept, I choose to use Glutathione. Glutathione is a tripeptide with 
a cysteine in the middle. Further I would like to analyze a longer peptide but fix the 
amount of cysteines in the sequence, that is why I have chose Insulin Like Growth Factor 
as our second model peptide. Insulin Like Growth Factor is a fourteen amino acid peptide 
with a cysteine in the middle. As our model peptide with two available cysteines in the 
sequence I have chosen a nine amino acid peptide [Thr4,Gly7] Oxytocin. I further 
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analyze another derivative of the same peptide, which differs only by the availability of 
basic amino acids. Somatostatin-14 was chosen to be our final model peptide due to the 
fact that it contains two cysteines in the sequence and one of them is located on the C-
terminus of the peptide. 
In Chapter II I will talk about experiments I set up for the projects and the results 
I obtained. I will be using peptides containing cysteine in the sequence. The modification 
with bromide-peroxyester will be performed by the cysteine residue (Scheme 20). 
0 
Br~o'0t 
Scheme 20. Modification of a cysteine by peroxyester. 
I will analyze the peptide fragmentation before the modification and after the 
modification (Scheme 21 ). What I expect to see before the modification is the standard 
b/y fragmentation pattern. After the modification I expect to see an increase in mass of 
the analyte. I then generate the radical species from the chemical modification by the 
means of collision induced dissociation. The predominant peak observed corresponds to 
radical derived product almost in all of the peptides used. After the radical derived 
product is identified, its fragmentation is also studied. 
33 
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Scheme 21. General idea of the study. 
The study starts with modification of Glutathione (a tripeptide with a cysteine in the 
sequence). The preliminary mechanism ofthe fragmentation was suggested after 
comparative analysis of the modified and unmodified Glutathione. The next set of 
experiments is performed on Insulin Like growth Factor (a longer peptide containing only 
one cysteine in the sequence). Further a more complicated scenario is analyzed. Oxytocin 
is a 9 amino acid long peptide with two cysteines in the sequence one of which is on the 
N-terminus and the other is in the middle of the chain. Both possible mono modifications 
are analyzed as well as the di-modified adduct (Scheme 22). 
Jp·rl 
HS SH 
d
.f. . J·rl mono mo 1 1cat1on 
x/s SH 
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Scheme 22. Mono and di modification ofthe peptide. 
And in the end of Chapter II the longest peptide with two cysteines is analyzed. All the 
results are discussed in Chapter II and the conclusions are made. 
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CHAPTER II 
RESULTS AND DISCUSSIONS 
In this chapter, I will introduce the synthesis of the organic peroxy ester that will 
be further used to modify the peptides. I will discuss why this modification was chosen 
and what transformations it undergoes in ESI CID. Secondly, I will examine how 
chemical modification of Glutathione influences its fragmentation pattern in the mass 
spectrum. The studies of the modification and fragmentation patterns of Insulin Like 
Growth Factor, two varieties of Oxytocin and Somatostatin-14 follow with the reasoning 
of the chosen peptides and the fragmentation analysis. Finally the research results are 
summarized and the conclusions are made. 
For the introduction of the radical species in the peptide sequence it was decided 
to use peroxyesters. As it will be shown further, the radical species are generated from 
peroxyester with the help of CID. When exposed to CID the peroxy bond breaks down 
homolitycally producing radical species. A range of peroxyesters were analyzed in a 
previous study in our laboratory and it was found that the peroxyesters with five carbon 
chain (C5) gave the most intensive radical derived product in mass spectrum. 1 Since the 
main aim of the research project is to analyze the radical derived fragmentation 5-bromo-
t-butyl ester ofperoxypentanoic acid was chosen as a model compound (Scheme 23). 
0 
Br~CI + 
2.1 
Scheme 23. Synthesis of five carbon peroxyester. 
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Figure 11. Glutathione (GSH). 
Exact Mass: 308.09 
Mol. Wt.: 308.33 
Glutathione is a tri peptide with one cysteine in the middle and molar weight of 
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308.33 g/mol. The only possibility for forming disulfide bond is between two molecules 
of Glutathione (Figure 12). 
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Figure 12. Oxidized Glutathione( GSSG). 
First the mass spectrum of unmodified glutathione was obtained and confirmed the 
presence of oxidized form of peptide (Figure 13). 
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Figure 13. The Glutathione mass spectrum. 
The CID analysis on the reduced Glutathione gave standard fragmentation 
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pattern: b/y fragmentation: b3 (290), b2 (233), Y2 (179) (Figure 14). Further, Glutathione 
was modified with peroxyester (Scheme 24). 
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Figure 14. CID ofunmodified Glutathione. 
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Scheme 24. Modification of Glutathione with C5 peroxyester. 
The reaction was monitored by mass spectrometry until the starting peptide was 
gone from the reacting mixture. On the line with the target product of the modification, 
several other side products were observed. M/z 608 is thought to be an adduct of 
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Glutathione with DIPEA (molar weight is 129 g/mol) in addition to peroxyester, which is 
used in the modification reaction (Figure 15). 
2.8 
Exact Mass: 608.35 
Molecular Weight: 608.79 
Figure 15. Modified Glutathione adduct with DIPEA. 
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Figure 16. Mass spectra of modified Glutathione. 
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CID was performed on the modified adduct. Based on previous research 
conducted in the laboratory the mechanism of the decomposition (Scheme 25) of the 
radical species in the gas phase starts from the decomposition of the peroxy - 0-0- bond 
(2.7) and is followed by decarboxylation (2.9), finally a five-membered ring is formed 
(2.1 0) and tetrahydrothiophene leaves the peptide (Scheme 25). As a result, alanine with 
a radical on the side chain is generated instead of cysteine (2.11 ). The observed radical is 
thought to further undergo 1-2 shift, which allows to a more stable radical species 
formation (2.12). Radical species 2.12 is stabilized by captodative effect, described in the 
first chapter. The introduction of the chemical modification of cysteine with further 
generation of the radical species from the chemical modification, overall allows in-gas 
mutation of cysteine to alanine radical (Ala·) avoiding the genetic engineering step. 
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Scheme 25. Mechanism of radical generation in the gas phase. 
The presence of cysteine in the peptides is known to complicate the mass 
spectrometry analysis. Since -SH group of the cysteine possesses nucleophilic properties, 
tendency of cysteine to nucleophilically attack carbonyl carbons in the peptides and 
disulfide bonds formation has been described previously? The introduction of the 
chemical modifications allows solving this complex problem by removing -SH grouping 
upon radical generation. In addition to this, introduction of the radical species in the 
peptide sequence forces non-standard fragmentation of the peptides to take place. Non-
standard fragments (x, c, z) could also serve as complimentary information source when 
determining the sequence of a peptide from the mass spectrum data. 
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Figure 17. CID on the protonated modified Glutathione( b' 2 is the Ala• derived 
fragment). 
The modified adducts were studied with several counter ions: H+, Na+, K+, Li+. The 
spectrum obtained from the analysis of cation adducts shows a reproducible 
495.08 
500 
fragmentation pattern with different intensities of the peaks, when varying cations. This 
difference can be explained by the fact that in the presence of cations, the proton 
migration possibility is excluded and as a result more of the radical derived fragmentation 
is observed. As an example the sodiated adduct spectrum can be found on Figure 18. 
Mass of the sodiated adduct is 502 rn/z. And the mass of the main product generated by 
exposing sodiated adduct to CID corresponds to the radical derived adduct. 
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Figure 18. CID on sodiated modified glutathione. 
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So far, we can observe different fragmentation patterns in the first generation CID 
on the modified Glutathione, although Ala· is observed in abundance in both cases. In 
case of unmodified glutathione, we saw the standard b/y fragmentation. On the other 
hand in case of the modified glutathione we observe predominantly the radical derived 
product formation. The intensity of the radical derived product increases as we change 
the counter ion to a metal. In case ofNa+, Lt, and K+ the radical derived product is the 
most dominant daughter ion of the CID performed on the modified Glutathione. 
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Figure 19. The predominant radical derived adduct observed in the CID spectrum of C5 
modified Glutathione. 
Moving further, the second generation CID on the radical derived ion was 
analyzed. In case of protonated radical derived ion, the most intensive peak observed 
corresponds to decarboxylation. The rn/z 212, 201 , 173 and 146 correspond to standard 
b/y fragmentation, except one modification: instead of the cysteine, alanine radical is 
present. We will further call it Ala• derivative (Figure 20). 
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Figure 20. CID on protonated Ala·. 
After the analysis of the obtained spectrum, fragment with rn/z 182 attracted out 
attention, because of several different structures that correspond this rn/z. Since the gas 
phase processes are not yet completely understood, one must be careful assigning a 
structure to an observed fragment this is why we are offering all the structures that 
correspond to this mass plus suggested pathway (Scheme 26). 
or 
+ 
H2:~H2 2.14 
0~ 0 
HN.,..)lN~O 
1 H OH 
Exact Mass: 275.11 
Molecular Weight: 275.26 
O:s+OH2 
HN -
0 HO N 
H 2.16 
Exact Mass: 200.08 Exact Mass: 200.08 
Molecular Weight: 200.19 Molecular Weight: 200.19 
O:s+OH2 
N~ 
, fFO 
2.17 ~~ 
Exact Mass: 182.07 
Molecular Weight: 182.18 
0~ 0 
•. ,.
6Yy 
49 
Exact Mass: 200.08 Exact Mass: 182.07 
Molecular We1ght: 200. 19 Molecular Weight: 182.18 
Exact Mass: 200.08 
Molecular Weight: 200.19 
Exact Mass: 183.05 
Molecular Weight: 183.16 
Scheme 26. Three ofthe possible structures for rn/z 182. 
The sodium, lithium and potassium adducts of the modified glutathione were analyzed 
further. The fragmentation pattern of the cation adducts was found to be different from 
the protonated. 
The main fragment observed in the CID on sodiated Ala· has m/z of 210 and 
believed to be a product of the radical migration by hydrogen abstraction (Scheme 27). 
The pattern is reproduced with other cations. 
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Scheme 27. Fragmentation of the sodiated Ala·. 
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Figure 21. CID on sodiated Ala· . 
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An attempt in online modification of Glutathione with C5 was taken. Several 
different conditions were analyzed, although the observed signal was not intensive 
enough to tune the device, the presence of the product of the reaction was observed on 
50 
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the level with noise. An average reaction time is one hour, minimum reaction time is 
thirty minutes. Next peptide that was analyzed was Insulin Like Growth Factor (ILGF). 
Insulin-Like Growth Factor (ILGF) experiments 
Insulin Li~e Growth Factor is a 14 amino acid peptide with a cysteine in the 
middle ofthe peptide (Figure 22). 
Figure 22. Insulin Like Growth Factor. 
The standard b/y fragmentation was observed in the CID on protonated 
unmodified peptide. When introducing the modification the mass of the peptide peak 
increased by the mass of the peroxyester. The CID on the modified ILGF was performed 
and the main product observed is the peptide with the Ala• in the sequence instead of 
cysteine. This proves the repeatability of the experiment. Further CID on the newly 
generated peptide was performed. Three most intensive products were observed: y12, Yl3 
and x13• The rest of the products were not as intensive, but still corresponded to the 
fragmentation of the peptide bearing an alanine radical instead of cysteine. Among less 
intensive fragments a7 was observed in the line with y fragments and a couple of z 
fragments . 
The sodiated adduct was also analyzed. The Ala• is the main daughter ion formed 
when CID on the sodiated modified ILGF is performed. The CID is further performed on 
the Ala•. The observed fragmentation is more diverse than in the standard b/y case (x, c 
and z fragments are also observed), although overall less fragments are formed. The 
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observed fragments are y, c, z, x and a radical derived fragment corresponding to the 
backbone breakdown in close proximity to the radical location (Figure 23). The closest 
by mass determined structure differs from the one observed in the mass spectrum by 2 
mass units, which could probably be explained by some radical processes that would 
require some additional computer calculation experiments. 
2.26 
Figure 23. Fragmentation of in close proximity to the radical location. 
Further two different Oxytocin sequences were analyzed: [Thr4,Gly7] Oxytocin 
(940 g/mol) and Oxytocin (1007.2 g/mol) with the standard sequence. In case of both of 
the Oxytocin sequences, they contain two cysteine residues, two different mono 
modifications and a di modified adduct were analyzed. 
[Thr4,Gly7] Oxytocin experiments 
[Thr4,Gly7] Oxytocin is a nine amino acids peptide with cysteine in theN-
terminus position and in the middle (Figure 24). 
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Figure 24. [Thr4,Gly7] Oxytocin. 
CID on unmodified [Thr4,Gly7] Oxytocin gives b, y and z fragments. There are two 
possible mono modifications of the peptide with C5 (Scheme 28). 
Exact Mass: 1114.53 
Mol. Wt.: 1115.34 
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0 
Scheme 28. Mono modification of [Thr4,Gly7] Oxytocin 
Since there are two possible mono modifications that take place, a mixture of two 
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possible Ala· with the same mass was present when the CID on the modified adduct was 
performed (Figure 25). An experiment to confirm the presence of both modifications was 
also set up. 
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Figure 25. Two possible Ala·derived from two possible modifications of 
[Thr4, G l y7] Oxytocin 
A closer analysis of mono modified [Thr4,Gly7] Oxytocin was conducted. An 
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attempt to prove that modification takes place on both cysteines. The fragmentation from 
the CID on mon Ala was analyzed in detail (Figure 27). 
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Figure 26. Fragmentation pattern observed in the mass spectrum. 
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Figure 27. CID on mono Ala· [Thr4,Gly7] Oxytocin (the underlined fragments 
correspond to radical formation on the middle cysteine, NOT underlined correspond to 
the radical formation on cysteine closer toN-terminus) 
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From the mass spectrum of mono Ala· (Figure 27), one can see the most intensive peaks: 
908 (parent), 891 (parent- NH3), 873 (parent- NH3- H20), 834 (bs), 702 (x7 ofN-
terminus Ala·), 676.04 (y7 ofN-terminus Ala·) 618 (86- C02), based on this assignment, 
we concluded that both kinds of modifications take place (Figure 26). 
Another experiment was set up to find out which modification takes place first 
and which modification is predominant. First, reduced [Thr4,Gly7] Oxytocin was reacted 
with iodoacetamide to modify only one cysteine residue. Further, the reaction mixture 
was reacted with five carbon bromperoxyester (Scheme 29). 
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Scheme 29. Mono modificattion of [Thr4,Gly7] Oxytocin with Iodoacetamide and C5. 
The fragmentation pattern of the obtained Ala· was analyzed (Figure 28). 
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Figure 28. CID on mono alkylated Ala·. 
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From the spectrum interpretation, it was found that peak 652 corresponds to the bs 
fragment ifthe Ala· radical was on the middle cysteine and mass of562.92 corresponds 
to the b5 fragment if the Ala· was on theN-terminus. Since the fragments are the same 
one could suppose that the intensities can be compared, however it is known that 
alkylation with amide group allows adduct to pick up charge better, which could lead to a 
better intensity of the adduct peak in the mass spectrum. So the fragment with the Ala· in 
the middle would have acetamide modification on theN-terminus, which would make the 
signal more intensive. However, mass 529 corresponds to y6 fragment of the peptide with 
Ala· in the middle (acetamide modification cut off) and 619.99 fragment corresponds to 
Y6 of Ala· with acetamide in the middle, which should make the signal more intensive, 
however the intensity of this mass is lower. In conclusion, one can suppose that the 
modification with peroxyester is predominantly located on the middle cysteine, when in 
competition with iodoacetamide. Further unmodified Oxytocin was analyzed. 
Oxytocin experiments 
Oxytocin is a nine amino acid peptide with two cysteines in the sequence (Figure 
29). The main difference from the previously analyzed sequence of Oxytocin is the 
presence of glutamine in the fourth position and proline in the seventh. It is known that 
the presence of basic amino acids can influence the fragmentation pattern ofthe peptide. 
As it has been described in previous publications, the presence of basic amino acids 
increases the energy input requirement for the peptide fragmentation initiation.3 
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Figure 29. Unmodified Oxytocin. 
The Ala· derivative was generated under the CID conditions and was observed as 
a major peak. Further the reaction mixture was analyzed by HPLC-MS (Figure 30). One 
ofthe major peaks in the spectrum corresponds to z7 fragment of the Ala· in the middle 
(Figure 31 ). This observation allows us to conclude that in case of mono modification of 
Oxytocin, the modification tends to go by the middle cysteine predominantly. 
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Figure 30. HPLC-MS of mono modified Oxytocin. 
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Figure 31. z7 fragment. 
To support this conclusion an experiment with alkylation by iodoacetamide was 
conducted followed by alkylation with five carbon 1-brompreoxyester. The fragmentation 
of the mono alkylated Oxytocin by iodoacetamide supported the proposed hypothesis. In 
conclusion in the fragmentation pattern of Oxytocin derived Ala· we observed less 
fragmentation than in the [Thr4,Gly7] Oxytocin derived Ala•, which fits the model ofthe 
higher energy input requirement to break the sequences with basic amino acids. Further a 
peptide with a cysteine on the C-terminus was analyzed. 
Stomatostatin-14 experiments 
Somatostatin-14 is a 14 amino acids peptide with two cysteines (Figure 32). One 
of the cysteines is located on the C-terminus and the other one two amino acids away 
from theN-terminus. 
Figure 32. Somatostatin-14. 
Modification of somatostatin-14, was studies by the means of mass spectrometry 
and liquid chromatography combined with mass spectrometry. In case of the absence of 
modification standard b/y fragmentation was observed. Once the modification is 
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introduced, the adduct with Ala· was observed, although it is the first case when the 
intensity of another radical derives ion was observed to be higher than Ala· (Figure 33). 
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Figure 33. CID on the modified somatostatin-14. 
The most intensive fragment observed in the mass spectra corresponds to the radical 
derived species after decarboxylation (Figure 34). 
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Figure 34. Main fragment in the CID on the modified somatostatin-14. 
One of the possible structures corresponding to Ala· (Figure 35), the second possible 
structure would have radical Ala· on the C-terminus. 
Figure 35. One of the possible structures of Ala·. 
From the CID on Ala• it was determined that the modification predominately goes by the 
cysteine located closer to theN-terminus, although for the confirmation of the results, the 
fragmentation was also analyzed after the HPLC separation (Figure 36). 
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Figure 36. LC-MS on Ala•·. 
From the obtained mass spectrum earlier made supposition was confirmed and an 
observation of a proton loss was made in the formed fragments, which can be explained 
by the radical transformation into alkene (Scheme 30). 
Scheme 30. The proton loss in Ala•. 
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Conclusions 
After analyzing the mass spectrum data from several different peptides before and 
after the chemical modification, one can say without a doubt that the introduction of the 
peroxyester modification allows facilitation of the data interpretation. 
Modification takes place. 
Modification of the peptides with peroxyester takes place. No evidence of the 
oxidation of thiol group of cysteine was found. The reaction of modification is 
reproducible, and does not require purification before the analysis. The reaction takes 
place selectively by the cysteine residue. The presence of cysteines in a newly isolated 
peptide can be determined with a help of the chemical modification. The amount of the 
cysteines present would equal to the amount of modifications taking place. 
Radical derived fragmentation. 
With the help of CID on modified peptides a stable radical fragment is generated 
(Ala•). The formation of Ala• derivatives ofthe peptides takes place and is proved to be a 
reproducible process. This allows conducting a selective gas-phase mutation of cysteine 
to alanine radical without genetic engineering. Having alanine instead in cysteine in the 
sequence of a peptide significantly facilitates the mass spectrum interpretation, due to the 
fact that - SH group of cysteine is no longer a threat for nucleophilic interactions in gas-
phase that complicate the spectrum. 
When comparing the fragmentation pattern of unmodified peptide with the 
fragmentation pattern of the radical derived analog, one can observe the appearance of 
new type of fragments. Although the amount of the new observed fragments depends on 
the length of peptide, presence of basic amino acids, and location of the cysteine. Thus in 
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case of Insulin Like Growth Factor with a cysteine in the middle of the peptide, the most 
diversity in the fragmentation pattern is observed to appear in the mass spectrum of Ala• 
compared to the protonated peptide. This observation could be an additional source of 
fragmentation information, when determining a sequence of a newly isolated peptide. 
C-terminus modification. 
No proof was found of the chemical modification taking place on the C-terminus of 
the peptide when there is another readily available cysteine. This result could be specific 
to Somatostatin-14 only; more experiments will be needed to make a definite statement. 
Cation adducts fragmentation. 
I came across some difficulties in assigning structures to the observed mlz in case 
of cation counter ions. When a cation used as a counter ion, the possibility of the proton 
migration is eliminated and the fragments tend to have more of a radical character. More 
detailed studies probably involving computer simulations and calculations could help in 
working on this point. 
In the following chapter, one can find the experimental details and all the obtained 
spectra for the experiments described above. 
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CHAPTER III 
EXPERIMENTAL 
General Experimental 
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All solvents and reagents used in the synthesis of the peroxyester esters were 
obtained from BDH or Aldrich and used as received. MS, MS/MS, LC-MS analysis was 
conducted on an LXQ spectrometer. The separation of the peptide adducts was 
accomplished by Rigel HPLC column, 5j..lm C18 4.6*250mm. All buffers listed below are 
prepared by standard procedures. 
Solutions used in the experiments 
Mass spectrometry wash solvent: acetonitrile/water (1: 1) with 1% of acetic acid. 
0.5mM solutions ofNaCl in water/ methanol (1: 1) 
Reduction buffer (2.5j..lmol ofDTT in 50!-lL of0.5 M NH4C03, pH = 8) 
Peroxy ester stock solution (6.2 mg/ 100 IlL ofMeCN, 4.8 j..lmol/20 IlL) 
General procedures 
Peptide sample preparation for mass spectrometry analysis 
90 IlL of the reaction mixture were diluted with 200 IlL of H20 and 100 j..lL of 
MeCN followed by the addiction of 1 0 IlL of acetic acid. 
Preparation of the samples with cation ions: 90 j..lL of the reaction solution were 
diluted with 100 IlL of water, 100 IlL of MeCN and a 100 IlL of a salt solution ( NaCl, 
KCI or LiCI) . 
Synthesis of 1-bromo-t-butyl-peroxypentanoate (3 .3) 
0 
Br~CI + 
3.1 
Pyridine ~ }Z_ 
Br 3.3 0-0 
5-bromo valery! chloride (3.1) (671 J..lL, 5 mmol) was dissolved in anhydrous 
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dichloromethane (5 mL) at room temperature. tert-butyl hydroperoxide (3.2)(912 J..lL, 5.5 
mmol) was diluted with CH2Cb (2 mL) and slowly added to the reaction flask. The 
solution was placed in an ice-bath and pyridine ( 405 J..lL, 5 mmol) was added slowly at 
0°C. The reaction was left to stir overnight at room temperature. Further, the reaction 
mixture was diluted with 2 volumes of ether, washed tree times with 10% HCl and tree 
times with 1.0 M NaOH, dried over MgS04, filtered and condensed under reduced 
pressure. Yield turned out to be 97% (1.23g, 4.85 mmol) and the compound was 
represented as yellowish oil. 1 H-NMR (400MHz, CDC~]): 3.43 (t, J = 7.29 Hz, 2H), 2.36 
(t, J = 7.3 Hz, 2H), 1.93 (m, 2H), 1.85 (m, 2H), 1.33 (s, 9H) 
0 ( SH 0 
9 ~~ ~ OH+ 
HO~ O 
NH2 
3.4 
Modification of the Glutathione. 
3.3 
0 
~0,0~ 
I o ( s o ~ 9 ~~ ~ OH 
HO~ O 
3.5 
NH2 
Solution of the peptide (3.4) (50 J..lL, 1mg/ 50 J..lL, 3 J..lmol) in NH4C03 buffer (0.1 M, 
pH= 8.0) was placed in a 500 J..lL reaction tube, solution ofperoxyester (3.3) (20 J..lL, 6.2 
mg/ 1 00 J..lL of MeCN, 4.8 J..lmol/20 J..lL) was added followed by DIPEA (1 0 J..lL), and 
diluted with 100 IlL of acetonitrile. The reaction mixture was allowed to shake at 25 oc 
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for 30 mins. The peptide samples for analysis were prepared following the standard 
protocol and the mass spectrum data was obtained. 
Modification of insulin like growth factor (ILGF) 
DIPEA 
0 
Br~o'0t 
3.3 
ILGF (3.6) (1 mg, 0.668 jlmol) was dissolved in 50 IlL ofNH4C03 buffer (0.1 M, pH= 
8.0). Peroxy ester (3.3) (20 j.!L, 6.2 mg/ 100 j.!L ofMeCN, 4.8 jlmol/20 j.!L) was added to 
the reaction mixture followed by DIPEA (6 j.!L) and acetonitrile (124 j.!L). The reaction 
was left to shake for 1 h at 25 °C. 
Mass spectrometry sample preparation and analysis were performed by the 
standard procedure described in the beginning of the experimental section. 
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Modification of [Thr4,Gly7] Oxytocin 
3.8 
Figure 37. [Thr4,Gly7] Oxytocin reduction. 
[Thr4,Gly7]0xytocin (3.8) (1 mg/1 Jlmol) was dissolved in 100 J.!L of reduction buffer 
(2.5J.!mol ofDTT in 50J.!L of0.5 M NH4C03, pH = 8) and nitrogen was bubbled through. 
The reaction was left for shaking for 35 minutes at 25 DC. 10J.!L aliquot was taken and 
diluted in 300 J.!L of mass spectrometry solvent (50% MECN/ 50% of H20/ 1% AcOH) 
for the reduction monitoring, the mass spectrum analysis was performed on the obtained 
solution. 
3.10 Exact Mass: 1114.53 
Mol. Wt.: 1115.34 
+ and/or 
Figure 38. Mono alkylation of [Thr4,Gly7] Oxytocin 
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0 
To the reduction reaction mixture (3.9) 100 J!L of acetonitrile were added followed by the 
addition of 10 J.tL ofperoxy ester stock solution (6.2 mg/ 100 J.tL ofMeCN, 4.8 J.tmol/20 
J!L) and 5 J!L ofDIPEA. The reaction was allowed to mix for 1 hat room temperature. 
HPLC gradient for the mass spectrometry analysis: solvent A: water with 0.1% of acetic 
acid. Solvent B: acetonitrile with 0.1% of acetic acid. Gradient: from 30% of B in A to 
34% over 5 mins and wash with 34% ofB in A for 20 mins. Rt =about 11-12 mins. 
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Figure 39. Di alkylation of [Thr4,Gly7] Oxytocin (3.12) 
To the reduction reaction mixture 100 j..tL of acetonitrile were added followed by the 
addition of37 j..tL ofperoxy ester stock solution (6.2 mg/ 100 j..tL ofMeCN, 4.8 j..tmol/20 
IlL) and 5 j..tL ofDIPEA. The reaction was allowed to shake at 25 °C for an hour before 
the analysis. 
Figure 40. Iodoacetarnide alkylation and peroxyester modification of [Thr4,Gly7] 
Oxytocin. 
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Reduction of [Thr4,Gly7] Oxytocin was performed as described above. 
Alkylation. 
To the reduced reaction mixture 10 11L of iodoacetamide solution (1 mmol, 20 mg 
in 9651-lL of HPLC water) was added, the reaction tube was wrapped in foil and left 
shaking for 1h at 25 °C. To the obtained reaction mixture added 10011L ofMeCN, 151-lL 
of peroxy ester stock solution (6.2 mg/100 11L of MeCN) followed by 5!lL of DIPEA. 
The reaction left shaking for an hour at 25 °C. Mass spectrum was obtained. 
Modification of Oxytocin 
HO••) + 
HS j 
< ··•OH 
SH 
0 0 0 0 0 0 0 0 0 
II H I I H I I H I I H II H I I II H II H II 
H2N~C-N~C-N~C-NI-N~C-N~c-z:;-c-N~C-N~C-NH2 
<(H2 ¢CH2 <(HCH3 yH2 yH2 <(H2 H 
SH _,._,.. CH2 C=O SH CHCH3 
....- I 0 I I I CH3 H N NH2 CH3 
3.19 ~ 2 
OH Exact Mass: 1 008.45 
Mol. wt.: 1009.2 
Figure 41. Reduction of Oxytocin. 
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Oxytocin ( 1 mg/ 1 J.lmol) was dissolved in 100 f.lL of reduction buffer (2.5 J.lmol of DTT 
in 50f.lL of 0.5 M NH4C03, pH= 8) and nitrogen was bubbled through. The reaction was 
left for shaking for 35 minutes at 25 DC. 1 Of.lL aliquot was taken and diluted in 300 f.lL 
of mass spectrometry solvent (50% MECN/ 50% of H20 / 1% AcOH) for the reduction 
monitoring, the mass spectrum analysis was performed on the obtained solution. 
0 0 0 0 0 0 0 0 0 
II H II H II H II H II H II II H II H II 
H2N~C-N~C-N~C-NI-N~C-N~c-vc-N~C-N~C-NH2 
9H2 ¢CH2 9HCH3 9H2 9H2 9H2 H 
SH _,.,_,., CH2 C=O SH CHCH3 / I 0 I I I CH3 H N NH2 CH3 
3.19 ~ 2 0 
OH Exact Mass: 1008.45] + Br~o"0t 
3.20 
0 
3.21 
Mol. IM..: 1009.2 3.3 
0 
Exact Mass: 1180.56 
Mol. IM..: 1181.42 
Figure 42. Mono modification of Oxytocin 
Exact Mass: 1180.56 
Mol. IM..: 1181.42 
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The reduction reaction mixture was diluted with 100 J..lL of acetonitrile followed by the 
addition of 10 J..lL ofperoxy ester stock solution (6.2 mg/ 100 ).!L ofMeCN, 4.8 J..lmol/20 
J..lL) and 5 J..lL ofDIPEA. The reaction was allowed to mix for 1 hat 25 °C. The mass 
spectrometry sample was prepared by the standard procedure. 
0 0 0 0 0 0 0 0 0 
I I H I I H II H II H I I H II II H II H II 
H2N-r-C-N-r-C-N-r-C-N~-N-r-C-N-r-C-z::s-C-N-r-C-N-r-C-NH2 
OH 
0 Exact Mass: 1352.67 ° 
3.22 Mol. wt.: 1353.65 -f 
Figure 43. Di alkylation of Oxytocin 
The reduction reaction mixture was diluted with 100 J..lL of acetonitrile followed by the 
addition of37 J..lL ofperoxy ester stock solution (6.2 mg/ 100 J..lL ofMeCN, 4.8J..lmol/20 
J..lL) and 5 J..lL ofDIPEA. The reaction was allowed to mix for 1 hat 25 °C. The mass 
spectrometry sample was prepared by the standard procedure. 
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Figure 44. Mono alkylation with iodoacetamide followed by alkylation with peroxyester 
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To the reduced reaction mixture 10 )JL of iodoacetamide solution (1 mmol, 20 mg 
in 965)JL ofHPLC water) was added, the reaction tube was wrapped in foil and left 
shaking for 1h at 25 °C. To the obtained reaction mixture added 100)JL ofMeCN, 15)JL 
ofperoxy ester stock solution (6.2 mg/ 100 )JL ofMeCN) followed by 5)JL ofDIPEA. 
The reaction left shaking for an hour at 25 °C. Mass spectrum was obtained. 
Modification of somatostatin-14 (sst -14) 
Figure 45. Reduction of sst-14 
QH 
+ HS~SH 
OH 
s 
Somatostatin-14 (3.27) (1 mg) was dissolved m 50 )JL of the Reduction Buffer. The 
reaction was blown through with nitrogen and left shaking for 1 hour at 25 °C. 
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Figure 46. Somatostatin-14 mono alkylation 
Reduction mixture reaction was diluted with 1 00 IlL of acetonitrile, and 6 IlL of peroxy 
ester solution (6.2 mg/100 IlL ofMeCN, 4.81-!mol/20 IlL) was added followed by 5 IlL 
ofDIPEA. The reaction mixture was left stirring for an additional hour at 25 DC. The 
samples for analysis were prepared following the method described above. 
Software used for the fragmentation pattern interpretation 
Fragment Ion Calculator: free web based program, allows input of the analyzed sequence 
and calculates a/x, b/y and c/z fragments. The software can be found following this link: 
http://db.systemsbiology.net:8080/proteomicsToolkit/FraglonServlet.html 
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Figure 4 7. NMR spectrum of peroxyester. 
